What Drug Companies and the FDA Need from Us

If you are interested in learning more about clinical trials, how new drugs come to market and what this means for NMO, TM, ADEM, Dr. Benjamin Greenberg’s presentation at the 2013 Rare Neuro-immunologic Disorders Symposium shares what we need to know and what the future looks like!

[youtube]https://youtu.be/lemEpjSGcj0[/youtube]

To view other videos from the 2013 Rare Neuro-immunologic Disorders Symposium hosted by SRNA, please click here.